Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 02, 2018
High-dose cytarabine (HD araC) in the treatment of leukemias: a review.
Journal: Current hematologic malignancy reports
Published: May 14, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026